Recent Locally Advanced Stage III (C) Prostate Cancer News

Combination Hormone Therapy Appears Safe and Effective in Reducing Testosterone in Metastatic Prostate Cancer (June 18, 2014)

In a study presented at the 2014 American Society of Clinical Oncologists meeting, researchers reported that the use of two hormone blocking agents—Xtandi® (enzalutamide) and Zytiga® (abiraterone)—appeared... Continue Reading

High Incidence of Many Complications after Surgery or Radiation for Prostate Cancer (February 27, 2014)

Men who undergo surgery or radiation therapy for prostate cancer may face a variety of complications in addition to incontinence and erectile dysfunction—including high rates of hospitalization, urologic... Continue Reading

Metformin May Improve Survival in Diabetic Men with Prostate Cancer (September 4, 2013)

Diabetic men with prostate cancer lived significantly longer and were significantly less likely to die of prostate cancer when treated with metformin, an insulin-lowering drug, according to the results... Continue Reading

ASTRO and AUA Issue Joint Guideline for Radiation After Prostate Surgery (June 19, 2013)

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) have issued a joint guideline regarding the use of radiation therapy after prostatectomy. It marks the... Continue Reading

Genomic Test May Help Guide Prostate Cancer Treatment (May 13, 2013)

A new genetic test—the Oncotype DX® Prostate Cancer Test—measures the aggressiveness of prostate cancer and may help scores of men choose between immediate treatment or active surveillance. The test... Continue Reading

Early Radiation Improves Prostate Cancer Survival (March 7, 2013)

Immediate radiation therapy after radical prostatectomy resulted in a 50 percent increase in long-term biochemical progression-free survival (bNED) in men with locally advanced prostate cancer, according... Continue Reading

No Difference in Toxicity Between Proton Therapy and IMRT for Prostate Cancer (January 28, 2013)

Proton therapy does not reduce toxicity compared with intensity-modulated radiation therapy (IMRT) in men with prostate cancer, according to the results of a study published in the Journal of the National... Continue Reading

Viagra Improves Sexual Function after Radiation for Prostate Cancer (November 15, 2012)

Viagra® (sildenafil citrate) administered before, during, and after radiation therapy improved overall sexual function in prostate cancer patients, according to the results of a study presented at the... Continue Reading

Intermittent and Continuous Hormone Therapy are Equally Effective in Prostate Cancer Treatment (September 18, 2012)

Hormone therapy given intermittently (with breaks) has proven to be as effective as hormone therapy given continuously in asymptomatic men with rising PSA levels after prostate cancer treatment, according... Continue Reading

Men with Cardiovascular Disease More Likely to Regret Prostate Cancer Treatment (July 10, 2012)

Prostate cancer patients with cardiovascular disease were 52 percent more likely to regret their treatment choices than their counterparts, according to a study published in BJUI International. Prostate... Continue Reading

Next Page »